Dr. Andrea L. Wirtz, an assistant scientist in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, has received a $4 million, three-year grant from the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, and National Institute of Mental Health. Dr. Wirtz is teaming with Dr. Sari Reisner from Harvard T.H. Chan School of Public Health/Boston Children’s Hospital to study sociobehavioral risk factors for HIV acquisition among transgender women. The study will also examine access to biobehavioral HIV prevention methods and linkage to care for those who become infected with HIV over time.
The American Cohort (commonly known as the LITE study) establishes a multi-site, prospective cohort of transgender women in the eastern and southern U.S. Study findings will provide epidemiologic parameters for future human immunodeficiency (HIV) prevention and care research among transgender women, offer a platform upon which other health research questions can be explored, and inform the development and testing of evidence-based and acceptable HIV prevention interventions for the population.
Dr. Wirtz is an epidemiologist with expertise in infectious disease. She focuses on the epidemiologic assessment of infectious disease, violence, and health among underserved populations.Tags: Friday Letter Submission, Publish on October 18